Skip to main content

Table 2 Susceptibility profile of uropathogens isolated from symptomatic outpatients at Gulu regional hospital, northern Uganda (n = 82)

From: Antibiograms from community-acquired uropathogens in Gulu, northern Uganda - a cross-sectional study

Uro-isolates

Staphylococcus spp. n = 38

E. coli n = 32

Klebsiella spp. n = 4

P. mirabilis n = 2

E. faecalis n = 6

Antibiotic disks

S

I

R

S

I

R

S

I

R

S

I

R

S

I

R

Nitrofurantoin (50 μg)

8

14

16

10

5

17

0

1

3

0

0

2

4

0

2

Nalidixic acid (30 μg)

4

10

24

13

6

13

0

2

2

0

0

2

2

2

2

Cotrimoxazole (25/125 μg)

5

5

28

5

5

22

0

0

4

0

0

2

2

0

4

Amoxicillin (10 μg)

16

6

16

10

3

19

0

1

3

0

2

0

2

0

4

Amoxi/clav (20/10 μg)

26

3

9

10

10

12

0

4

0

0

2

0

3

1

2

Cephalexin (30 μg)

16

13

9

5

8

19

3

1

0

0

0

2

2

0

4

Ciprofloxacin (5 μg)

24

0

14

19

5

8

3

1

0

2

0

0

4

0

2

Levofloxacin (5 μg)

29

2

7

13

9

10

2

2

0

2

0

0

3

1

2

Gentamicin (10 μg)

24

7

7

26

1

5

4

0

0

2

0

0

6

0

0

Azithromycin (15 μg)

6

9

23

10

17

5

4

0

0

1

1

0

5

1

0

Oxacillin (10 μg)*

7

0

2

-

-

-

-

-

-

-

-

-

-

-

-

  1. Key: S, Sensitive; I, Intermediate; R, Resistant; * tested on Staphylococcus aureus only (n = 9).